A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in

Who holds ELVNENLIVEN THERAPEUTICS

7 funds on our shelf carry ENLIVEN THERAPEUTICS — heaviest hand: XPH at 2.09% of its book.

FundWeightFund assetsShares held
XPHState Street SPDR S&P Pharmaceuticals ETFINDEX2.09%$487M176,696
IHEiShares U.S. Pharmaceuticals ETFINDEX0.68%$1.6B226,896
DWASInvesco Dorsey Wright SmallCap Momentum ETFINDEX0.37%$411M33,482
IBBQInvesco Nasdaq Biotechnology ETFINDEX0.23%$112M5,236
IBBiShares Biotechnology ETFINDEX0.20%$10.6B458,860
IWOiShares Russell 2000 Growth ETFINDEX0.18%$14.4B545,904
VHTVanguard Health Care Index FundINDEX0.04%$19B147,176

LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.